Pharmacy integration connects prescribing systems, dispensing systems, and pharmacy networks so prescriptions, refill requests, cancellations, and medication history move reliably between them. It transmits and reconciles. It does not prescribe, authorise a refill, substitute a product, or decide that a medication is appropriate for a patient.
Pharmacy interfaces carry a legal instrument, not a data record. A dropped cancellation means a patient collects a drug their prescriber stopped, and a refill request answered by the wrong provider is a compliance problem. Taction builds pharmacy integrations where the transaction states nobody demonstrates in a sales meeting are the ones designed first.
Our experts are ready to understand your business goals.
Most pharmacy integration failures are transaction-state failures: a cancellation that never sent, a renewal sitting unanswered for eleven days, a change request the prescriber never saw. We build the full transaction set and the worklists around it rather than the happy path plus a backlog. Where the requirement is a pharmacy-facing product rather than interfaces between existing systems, our pharmacy application development work covers dispensing, operations, and patient-facing pharmacy software instead. The renewal worklist is a first-class part of that scope rather than an operational afterthought your practice managers inherit.
Certified transaction handling for new prescriptions, renewals, changes, cancellations, and history queries. Certification requirements apply to the components used and are treated as scope, not detail. Transaction coverage is agreed explicitly upfront.
Pharmacy lookup, patient preference, and mail-order handling built into the prescribing workflow. Pharmacy selection accuracy prevents the reroutes and phone calls that follow a wrong destination. Mail-order and specialty destinations behave differently.
Inbound requests routed to prescriber or delegate with ageing, escalation, and response tracking. Unanswered requests are reported by age, since silence is the common failure rather than error. Delegates are attributed individually.
Order transmission to dispensing equipment and administration data returning to the record, built on our HL7 integration services. Device interfaces each follow their vendor’s own specification. Administration data returning is part of the same scope.
Channels, retries, acknowledgement processing, and alerting delivered on Mirth Connect or your platform. Transaction monitoring covers failed sends, stuck queues, and unacknowledged messages. Alerts reach a named owner rather than a shared mailbox.
Prescriptions, history, and administration data landing in the record through our EHR and EMR integration services. Chart presentation decides whether clinicians trust what they see. History is labelled with its source and retrieval date.
Pharmacy integration spans outpatient e-prescribing across a national network, inpatient order transmission to dispensing systems, and the medication history queries that inform both. It sits inside a wider healthcare integration programme and connects to the broader medication management picture in your organisation. Outpatient and inpatient are genuinely different problems: one is a network transaction under federal and state prescribing law, the other is a local interface into cabinets, carousels, and infusion workflow. We scope those separately, because the certification path, the failure modes, and the compliance owner are different in each case.
A signed prescription travels to the patient’s chosen pharmacy with product, directions, quantity, and prescriber identity. Transmission integrity matters because the message is a legal instrument, not a notification. Our e-prescribing work covers it.
Pharmacies request renewals electronically and expect a structured response. Renewal routing must reach the responsible prescriber or an authorised delegate, and unanswered requests need an ageing worklist. Silence is the usual failure.
Prescribers cancel or change prescriptions after transmission, and the pharmacy must be told. Cancellation handling is the transaction most often skipped in a build and the one with real patient consequences.
Electronic prescribing of controlled substances carries identity proofing, two-factor signing, and audit obligations. EPCS requirements are regulatory constraints on your organisation, not features we can supply. We build to them and document how.
History retrieved from the network informs prescribing and reconciliation, with our Surescripts integration work covering that transaction. Fill history shows dispensing, not ingestion. Coverage varies with payer mix and participating pharmacies in your region.
Inpatient orders reach cabinets, robots, and IV workflow systems with administration data returning. Local interfaces use clinical messaging rather than the outpatient prescribing network. Each vendor’s specification and licensing terms govern what is possible.
We publish no figures on prescribing errors, callback volume, or refill turnaround, because those depend entirely on your prescriber behaviour, your pharmacy mix, and your current process. What we deliver is instrumentation so your team measures impact against its own data. The reliable benefits are transactional: prescriptions arriving intact, cancellations landing, renewals visible and ageing, and administration data returning. Each is boring and each is a place where the absence of engineering produces a genuine patient safety exposure. We would rather describe the transactions we implement than promise a reduction we cannot evidence.
Cancellations and changes are implemented, not deferred to a later phase. Transaction completeness closes the gap where a stopped medication keeps being dispensed. Change requests are handled with the same discipline as cancellations.
Inbound requests are attributed, aged, and escalated rather than accumulating in a shared queue. Ageing visibility turns a silent backlog into a manageable operational task. Escalation rules are yours to configure and adjust.
Fill history is retrieved and labelled with source and date inside the prescribing workflow. Source labelling lets prescribers judge what they are relying on. Prescribers see coverage limits rather than an implied complete list.
Inpatient administration flows back into the record rather than staying inside the dispensing system. Returned data makes the chart the complete account of what happened. Reconciliation and quality reporting both depend on that return path.
Failed sends, stuck queues, and missing acknowledgements alert a named owner. Transaction alerting is what distinguishes a monitored interface from a hopeful one. An unsent cancellation is treated as a safety event.
EPCS and prescribing compliance are your organisation’s obligations, not features we can install. Regulatory duties stay with you, and we build to them rather than around them. We document that boundary in writing.
We start with transaction scope and certification constraints, because those decide whether the project is a build or a configuration exercise. Discovery is paid and time-boxed and produces an itemised fixed-scope estimate with an honest recommendation. For outpatient prescribing specifically, using certified components or your EHR’s existing network connection almost always beats building your own, and we say so. Delivery runs in short increments validated against network and vendor test environments rather than local mocks. Prescribing is a certified, regulated path, and duplicating it usually adds compliance surface without any clinical return.
We establish which transactions you need and what certification applies to each. Certification scope frequently changes the recommendation from build to configure. Certified components are named in the estimate rather than assumed available.
EPCS identity proofing, two-factor signing, and state prescribing rules reviewed with your compliance team. Regulatory review precedes design, since it constrains architecture rather than decorating it. Your compliance team signs the constraints before build.
Transactions, worklists, chart integration, and monitoring built in increments with prescribers reviewing real workflow. Prescriber testing happens before rollout, not during it. Renewal and cancellation flows are demonstrated with real transactions.
Retry logic, unacknowledged message handling, ageing worklists, and alerting completed before go-live. Failure paths are a go-live condition rather than a later improvement. Named owners are assigned to each alert type before launch.
We work through network certification and each device vendor’s test process with your team. External test cycles run on their schedules, so other work continues in parallel. Their queues are not ours to shorten.
Phased cutover with heightened transaction monitoring, then handover with a runbook and named operational owners. Handover covers credentials, renewals, and escalation paths. Credential expiry dates are held by a named person afterwards.
We build to network and vendor specifications, using certified components where certification applies, and we treat prescribing law as a constraint your compliance team owns. Compliance work covers HIPAA safeguards, controlled substance requirements, state prescribing rules, and audit sufficient to reconstruct who signed what and when. Clinical checking presented during prescribing is advisory: the prescriber decides. We do not build systems that authorise, substitute, or refuse medications on their own behalf. Where a state’s prescribing rules and a network’s specification pull in different directions, we implement the stricter requirement and document the reasoning.
Prescribing transactions follow network standards, and certified components are used where required. Certification status is documented, and we make no claim on any vendor’s behalf. No partnership or reseller relationship is implied anywhere.
Prescribing, refill authorisation, product substitution, and therapeutic appropriateness are prescriber and pharmacist determinations. The system transmits and records them and generates none of them. No rule in the system originates a prescribing decision.
EPCS identity proofing, credentialing, and two-factor signing are institutional obligations. We implement to those requirements and never represent them as satisfied by our software alone. The evidence for an audit remains your organisation’s to produce.
Interaction and allergy checking presented at prescribing is advisory, sourced from your licensed drug database. Prescriber override is always available with the reason recorded. Alert volume is measured and reviewed rather than left to accumulate.
Signed prescriptions, cancellations, and responses are retained with full history and never overwritten. Transaction audit supports both regulatory inspection and case review. You can reconstruct exactly which instrument was transmitted and when.
Role-based prescribing and delegate rights, credential management, and monitored endpoints. Access control for prescribing rights is treated as a security boundary, not a preference. Prescribing rights changes carry the same change control as code.
We have been building healthcare software since 2013, which is over 12 years, and we have delivered more than 200 healthcare projects. Interface engineering is core practice here, and we built our own EHR platform, Voyant Health, so prescribing workflow and medication lists are working knowledge. We are ISO 27001 certified, our leadership brings more than 20 years of personal experience in the field, and we work from four US offices in Chicago, Cheyenne, Austin, and Sacramento. We will also tell you when your EHR’s certified connection already covers what you need.
We implement cancellations, changes, and renewals rather than the send path alone. Complete transactions are where patient safety exposure actually sits in pharmacy work. Worklists and ageing come with it rather than later.
Building Voyant Health means we understand prescribing interfaces, medication list behaviour, and how history must be presented before a prescriber relies on it. Presentation and transport are designed together rather than sequentially.
Taction is ISO 27001 certified, with documented access control, encryption, credential management, and change control that stands up to a security review. Prescribing credentials and their rotation practice are documented for review.
We tell you which prescribing obligations remain yours. Clear boundaries are more useful than a vendor implying that buying software resolves a regulatory duty. The boundary appears in the proposal, not only in conversation.
For outpatient prescribing, certified components or your EHR’s existing connection usually win. That recommendation costs us revenue and reduces your compliance surface. The recommendation appears in the discovery report in writing.
Four US offices in Chicago, Cheyenne, Austin, and Sacramento, with delivery overlapping your hours through network certification and cutover. Escalation reaches a named delivery lead rather than a support queue.
Pharmacy integration pricing turns on which transactions are in scope, whether controlled substances are involved, and how many dispensing systems you connect. The tiers below cover engineering. Third-party licensing, cloud infrastructure, data subscriptions, and hardware are separate from engineering cost and itemised clearly. Network transaction fees, certified component licensing, drug database subscriptions, and identity proofing services for controlled substance prescribing are all recurring vendor costs quoted as their own line items. Controlled substance work in particular carries identity proofing and audit costs that sit outside engineering entirely, and we name them upfront.
$40,000 to $80,000 for outpatient prescribing transactions with renewal worklist, history query, chart integration, and transaction monitoring at one organisation. One organisation, outpatient only, using certified components you already license.
$80,000 to $200,000 for the full outpatient transaction set plus inpatient dispensing interfaces, administration data return, worklists, and operational dashboards. This tier covers most health systems connecting prescribing and inpatient dispensing together.
Starting at $200,000 for multi-facility deployments, owned retail pharmacy routing, several dispensing vendors, and multi-state prescribing compliance architecture. Dispensing vendor count and multi-state requirements drive the final figure more than volume.
A paid, time-boxed discovery phase produces a transaction scope, certification and compliance constraint review, build or configure recommendation, and an itemised estimate. The transaction audit is yours whether or not we build.
Transaction count, controlled substance scope, dispensing vendor count, and multi-state requirements. Controlled substance work adds compliance effort well beyond its engineering size. Older dispensing equipment often needs bespoke transport built for it.
Budget annually for network specification changes, certification maintenance, credential rotation, monitoring, and EHR upgrade regression testing. Vendor fees are quoted separately from support. Certification maintenance recurs on the network’s schedule rather than yours.
If your renewal queue has no age reporting or you cannot say whether cancellations are reaching pharmacies, start there. A paid discovery phase gives you a transaction scope review, a certification and compliance constraint assessment, an audit of which transactions your current interfaces actually implement, a build or configure recommendation, and an itemised fixed-scope estimate. If your EHR’s certified connection covers the outpatient side, you keep the assessment and spend nothing further with us. Talk to our team about your dispensing estate.
These are the questions informatics leads, pharmacy directors, and compliance officers raise before scoping pharmacy work. Several concern boundaries that matter legally: what the software decides and what a prescriber or pharmacist decides. Others concern controlled substances, where the honest answer involves obligations no vendor can satisfy for you. Where an answer depends on your EHR’s existing certified connection or your state’s rules, discovery resolves it quickly. We would rather tell you that your EHR already covers the outpatient side than sell you a parallel prescribing path you will have to certify and maintain.
Use the existing certified connection if it covers your transactions and workflow. Prescribing is a certified, regulated transaction path, and duplicating it adds compliance surface without clinical benefit. Custom work earns its cost for inpatient dispensing interfaces, owned retail routing, systems outside the EHR, or worklists your vendor handles poorly.
No. Renewal requests route to the responsible prescriber or an authorised delegate, and a person responds. Automatic authorisation would move a prescribing decision into a rules engine, which is both a clinical and a legal problem. What we automate is routing, ageing, escalation, and response tracking around that decision.
No, and any vendor implying otherwise should worry you. Identity proofing, credentialing, two-factor signing, and audit obligations sit with your organisation and its providers. We build to those requirements and document how the implementation supports them, but the compliance duty and its evidence remain yours.
Because without them a pharmacy keeps dispensing a medication the prescriber stopped, and the patient keeps taking it. Cancellation is the transaction most often left out of an initial build because it is invisible in a demonstration, and it is the one whose absence causes actual harm.
No. It shows what participating pharmacies dispensed, not what was ingested, and coverage varies. We label source and date on every entry so prescribers can judge it themselves rather than treating retrieved history as a complete and current medication list. Treat it as a starting point for the conversation with the patient.
Usually, following each vendor’s interface specification and licensing terms. Capability varies by product and version, so we verify against your actual estate during discovery rather than promising a mechanism that may not be enabled or supported for your configuration. Licensing terms sometimes matter more than technical capability here.
Your email address will not be published. Required fields are marked *
Our expert reaches out shortly after receiving your request and analyzing your requirements.
If needed, we sign an NDA to protect your privacy.
We request additional information to better understand and analyze your project.
We schedule a call to discuss your project, goals. and priorities, and provide preliminary feedback.
If you're satisfied, we finalize the agreement and start your project.